Cargando…
Bioactive compounds with possible inhibitory activity of Angiotensin-Converting Enzyme-II; a gate to manage and prevent COVID-19
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229719/ https://www.ncbi.nlm.nih.gov/pubmed/32425303 http://dx.doi.org/10.1016/j.mehy.2020.109841 |
| _version_ | 1783534809636667392 |
|---|---|
| author | Dabaghian, Farid Khanavi, Mahnaz Zarshenas, Mohammad M. |
| author_facet | Dabaghian, Farid Khanavi, Mahnaz Zarshenas, Mohammad M. |
| author_sort | Dabaghian, Farid |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7229719 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72297192020-05-18 Bioactive compounds with possible inhibitory activity of Angiotensin-Converting Enzyme-II; a gate to manage and prevent COVID-19 Dabaghian, Farid Khanavi, Mahnaz Zarshenas, Mohammad M. Med Hypotheses Letter to Editors Elsevier Ltd. 2020-10 2020-05-16 /pmc/articles/PMC7229719/ /pubmed/32425303 http://dx.doi.org/10.1016/j.mehy.2020.109841 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to Editors Dabaghian, Farid Khanavi, Mahnaz Zarshenas, Mohammad M. Bioactive compounds with possible inhibitory activity of Angiotensin-Converting Enzyme-II; a gate to manage and prevent COVID-19 |
| title | Bioactive compounds with possible inhibitory activity of Angiotensin-Converting Enzyme-II; a gate to manage and prevent COVID-19 |
| title_full | Bioactive compounds with possible inhibitory activity of Angiotensin-Converting Enzyme-II; a gate to manage and prevent COVID-19 |
| title_fullStr | Bioactive compounds with possible inhibitory activity of Angiotensin-Converting Enzyme-II; a gate to manage and prevent COVID-19 |
| title_full_unstemmed | Bioactive compounds with possible inhibitory activity of Angiotensin-Converting Enzyme-II; a gate to manage and prevent COVID-19 |
| title_short | Bioactive compounds with possible inhibitory activity of Angiotensin-Converting Enzyme-II; a gate to manage and prevent COVID-19 |
| title_sort | bioactive compounds with possible inhibitory activity of angiotensin-converting enzyme-ii; a gate to manage and prevent covid-19 |
| topic | Letter to Editors |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229719/ https://www.ncbi.nlm.nih.gov/pubmed/32425303 http://dx.doi.org/10.1016/j.mehy.2020.109841 |
| work_keys_str_mv | AT dabaghianfarid bioactivecompoundswithpossibleinhibitoryactivityofangiotensinconvertingenzymeiiagatetomanageandpreventcovid19 AT khanavimahnaz bioactivecompoundswithpossibleinhibitoryactivityofangiotensinconvertingenzymeiiagatetomanageandpreventcovid19 AT zarshenasmohammadm bioactivecompoundswithpossibleinhibitoryactivityofangiotensinconvertingenzymeiiagatetomanageandpreventcovid19 |